NORTHSTAR HEALTHCARE INCOME, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.85 USD | -19.05% |
|
-19.05% | +44.07% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 250.4 | 171.9 | 109.6 |
| Enterprise Value (EV) 1 | 980.4 | 979.7 | 922.4 |
| P/E ratio | 9.94 x | -3.16 x | -0.71 x |
| Yield | - | - | - |
| Capitalization / Revenue | 0.95 x | 0.74 x | 0.56 x |
| EV / Revenue | 3.72 x | 4.21 x | 4.69 x |
| EV / EBITDA | 15.8 x | 13.3 x | 21.8 x |
| EV / FCF | 18.1 x | 28.3 x | 66.5 x |
| FCF Yield | 5.51% | 3.54% | 1.5% |
| Price to Book | 0.56 x | 0.58 x | 0.82 x |
| Nbr of stocks (in thousands) | 192,644 | 195,287 | 185,712 |
| Reference price 2 | 1.300 | 0.8800 | 0.5900 |
| Announcement Date | 3/18/22 | 3/27/23 | 3/22/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 273.6 | 297.3 | 236.1 | 263.8 | 232.8 | 196.7 |
| EBITDA 1 | 46.98 | 83.57 | 28.44 | 62.06 | 73.59 | 42.28 |
| EBIT 1 | -60.15 | 12.58 | -36.57 | 7.219 | 35.01 | 3.766 |
| Operating Margin | -21.99% | 4.23% | -15.49% | 2.74% | 15.04% | 1.91% |
| Earnings before Tax (EBT) 1 | -151.9 | -77.68 | -264.2 | 26.91 | -54.44 | -160.2 |
| Net income 1 | -151.6 | -76.96 | -261.5 | 25.07 | -54.1 | -156.9 |
| Net margin | -55.4% | -25.88% | -110.76% | 9.5% | -23.24% | -79.76% |
| EPS 2 | -0.8084 | -0.4071 | -1.379 | 0.1308 | -0.2784 | -0.8260 |
| Free Cash Flow 1 | 39.05 | 46.35 | 18.73 | 54.02 | 34.64 | 13.86 |
| FCF margin | 14.27% | 15.59% | 7.94% | 20.48% | 14.88% | 7.05% |
| FCF Conversion (EBITDA) | 83.13% | 55.46% | 65.88% | 87.05% | 47.07% | 32.79% |
| FCF Conversion (Net income) | - | - | - | 215.5% | - | - |
| Dividend per Share 2 | 0.3375 | 0.0287 | - | - | - | - |
| Announcement Date | 3/22/19 | 3/23/20 | 3/23/21 | 3/18/22 | 3/27/23 | 3/22/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,395 | 1,392 | 1,387 | 730 | 808 | 813 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 29.69 x | 16.66 x | 48.79 x | 11.76 x | 10.98 x | 19.23 x |
| Free Cash Flow 1 | 39.1 | 46.4 | 18.7 | 54 | 34.6 | 13.9 |
| ROE (net income / shareholders' equity) | -18% | -11% | -49% | 6.24% | -14.6% | -74.1% |
| ROA (Net income/ Total Assets) | -1.43% | 0.36% | -1.13% | 0.27% | 1.65% | 0.2% |
| Assets 1 | 10,610 | -21,557 | 23,220 | 9,257 | -3,277 | -76,567 |
| Book Value Per Share 2 | 3.920 | 3.500 | 2.150 | 2.300 | 1.530 | 0.7200 |
| Cash Flow per Share 2 | 0.3900 | 0.2200 | 0.3500 | 1.040 | 0.5300 | 0.4600 |
| Capex | - | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 3/22/19 | 3/23/20 | 3/23/21 | 3/18/22 | 3/27/23 | 3/22/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- NHHS Stock
- Financials NorthStar Healthcare Income, Inc.
